What is the NOAEL for N-(3-(Dimethylamino)propyl)docosanamide?
N-(3-(Dimethylamino)propyl)docosanamide has 12 NOAEL studies in the database. The lowest reported value is 2.96 mg/m3 via inhalation in Human. Source: ToxValDB GESTIS DNEL.
Also known as: EINECS 262-134-8, UNII-X4O854526J, Behenamidopropyl dimethylamine
CAS 60270-33-9
N-(3-(Dimethylamino)propyl)docosanamide (CAS 60270-33-9) is a chemical substance. Key regulatory status: REACH registered, 1 regulatory/inventory list, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
View cosmetic safety profile for Behenamidopropyl Dimethylamine →
N-(3-(Dimethylamino)propyl)docosanamide is classified GHS Danger (H315, H318, H319, H412, H314, H317) in the chemicals database but is allowed in EU cosmetics.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Canada; Personal care; Substances in PCP - Canada (4/2014) | Government of Canada | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =2.96 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB GESTIS DNEL |
| X4O854526J | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| =5 | mg/kg body weight | NOAEL | oral | rabbit | CIR Safety Assessment |
| >10 | % | NOAEL | oral | rat | CIR Safety Assessment |
| =70 | mg/kg body weight | NOAEL | dermal | rabbit | CIR Safety Assessment |
| =100 | mg/kg body weight | NOAEL | oral | rabbit | CIR Safety Assessment |
| =200 | mg/kg body weight | NOAEL | dermal | rabbit | CIR Safety Assessment |
| 5 | mg/kg body weight | developmental toxicity | oral | rabbit | Regulatory source |
| 10 | % | developmental toxicity | oral | rat | Regulatory source |
| 100 | mg/kg body weight | developmental toxicity | oral | rabbit | Regulatory source |
| 70 | mg/kg body weight | repeated dose toxicity | dermal | rabbit | Regulatory source |
| 200 | mg/kg body weight | repeated dose toxicity | dermal | rabbit | Regulatory source |
Showing 12 of 12 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | N-[3-(dimethylamino)propyl]docosanamide | 262-134-8 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
N-(3-(Dimethylamino)propyl)docosanamide has 12 NOAEL studies in the database. The lowest reported value is 2.96 mg/m3 via inhalation in Human. Source: ToxValDB GESTIS DNEL.
N-(3-(Dimethylamino)propyl)docosanamide appears on 1 regulatory/inventory list including Canada; Personal care; Substances in PCP - Canada (4/2014). Source: EPA CPDat.
Yes, N-(3-(Dimethylamino)propyl)docosanamide is also indexed as a cosmetic ingredient under the name Behenamidopropyl Dimethylamine. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB. All data traces to primary regulatory sources and is updated from official government databases.
N-(3-(Dimethylamino)propyl)docosanamide is classified GHS Danger (H315, H318, H319, H412, H314, H317) in the chemicals database but is allowed in EU cosmetics.
N-(3-(Dimethylamino)propyl)docosanamide also appears in cosmetics databases.